Loading company
AKAN · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$1.36+102.5%Nov 13 close
Figures through June 30, 2026, from the 6-K filed September 30, 2026
From the company’s own 6-K filing.
Akanda Corp. has no earnings call transcript available.
The quote and the company description come from the 6-K Akanda Corp. filed on September 30, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.